Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, announces that the Notice of Annual General Meeting (‘AGM’).
AbC-19TM test to monitor vaccine responses to variants of concern AbC-19TM able to detect antibody response to different vaccines as well as natural infection
Zak Mir takes a technical analysis look at some of the most followed small caps on the London market. Today’s selection includes Avacta, Omega Diagnostics, Open Orphan and Xtract Resources.
Diagnostics continue to surf the rollercoaster of the pandemic / post-pandemic period, something which has been underlined by the latest update from Omega Diagnostics (ODX) on the occasion of the
FOR THE YEAR ENDED 31 MARCH 2021
Peer-reviewed performance evaluation and self-test user experience of AbC 19TM
Zak Mir takes a technical analysis look at some of the most followed stocks on the London market. Today’s selection includes Ariana, Cora, Hummingbird, IAG, Kropz, Petro Matad, Omega Diagnostics,
Investment company All Active Asset Capital (AAA) provided a couple of lessons for stock market watchers. The first was that the bears were correct in suggesting AAA is not worth
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that following completion of the of US performance studies.
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the recent media comment that Mologic Ltd have requested for Porton Down to evaluate
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, provides the following update on VISITECT® COVID-19 Antigen test regulatory approvals.
